홈 › 비소세포폐암 › 텍사스

텍사스의 비소세포폐암 임상 시험

비소세포폐암 관련 연구 204개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 5, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07085091

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

University Of Texas Medical Branch At Galveston, Galveston
Kelsey-Seybold Clinic Main Campus, Houston
Texas Oncology - San Antonio, San Antonio
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07361510

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Hendrick Medical Center, Abilene
Houston Methodist San Jacinto Hospital, Baytown
Parkland Memorial Hospital, Dallas
외 6개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT04267848

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07189871

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

START Fort Worth, Fort Worth
MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07659782

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Texas Oncology - Amarillo Cancer Center, Amarillo
Texas Oncology-Austin Central, Austin
Texas Oncology, Denton
외 4개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07361497

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

NEXT Dallas, Irving

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07578571

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Joe Arrington Cancer Research /ID# 272776, Lubbock

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06772623

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Houston
Research Site, Round Rock

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Houston
PHN-012-001 Site, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07127874

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Texas Oncology - South Austin, Austin
Texas Oncology Dallas, Dallas
MD Anderson Cancer Center, Houston
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06881784

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Texas Oncology - DFW ( Site 8103), Dallas
UT Southwestern Medical Center ( Site 0190), Dallas
Houston Methodist Cancer Center ( Site 0191), Houston
외 5개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06623422

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Texas Oncology - West Texas, Abilene
Texas Oncology-Northeast Texas, Allen
Texas Oncology-West Texas, Amarillo
외 61개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07144280

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Dallas Cancer Specialists, Garland
Southwest Oncology Associates, Houston
Lumi Research, Houston
외 2개

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07227298

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Texas Oncology - West Texas, Abilene
Texas Oncology - Northeast Texas, Allen
Texas Oncology - West Texas, Amarillo
외 52개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07222566

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Dallas
Research Site, Galveston
Research Site, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06218914

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

The University of Texas, MD Anderson Cancer Center - Woodlands, Conroe
Renovatio Clinical - El Paso, El Paso
The University of Texas MD Anderson Cancer Center Diagnostic Imaging, Houston
외 10개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06758401

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Research Site, Round Rock

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06868277

Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer

UT MD Anderson, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07579221

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

University of Texas Medical Branch, Galveston
The University of Texas MD Anderson Cancer Center, Houston
Baylor Scott & White Health, Temple

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07154290

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Oncology Consultants PA, Houston
University of Texas MD Anderson Cancer Center, Houston
US Oncology Research Investigational Products Center, Irving

피험자 모집 중3상

18세 ~ 100세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05920356

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Texas Oncology South, Austin
Parkland Health and Hospital System, Dallas
Texas Oncology DFW, Dallas
외 8개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06667076

Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery

The University of Texas M. D. Anderson Cancer Center, Houston

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06919874

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06667908

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06172478

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

The Center for Cancer and Blood Disorders, Fort Worth
Kelsey-Seybold Clinic, Houston
Houston Methodist Hospital, Houston
외 4개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06890598

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Baylor, Scott and White Research Institute, Dallas

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06047379

Pan-tumor MRD Study

Onocology Consultants P.A. (Oncology Consultants [OC Houston]), Houston
Community Clinical Trials, Kingwood
Christus St. Michael's, Texarkana

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06605404

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Houston

피험자 모집 중2상

18세 ~ 95세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT05061550

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

UT Southwestern Medical Center at Dallas, Dallas

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07140016

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Research Site, Fort Worth
Research Site, Houston
Research Site, Kingwood
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06357533

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NEXT Oncology - Irving, Irving

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06618287

Intratumoral N17350 in Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07339176

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Texas Oncology - West Texas, Abilene
University of Texas MD Anderson Cancer Center, Houston
Local Institution - 0517, Houston
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06561386

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

MD Anderson, Houston
NEXT Dallas, Irving
NEXT Oncology San Antonio, San Antonio
외 1개

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Local Institution - 0025, Houston
Local Institution - 0173, San Antonio

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07100080

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Texas Oncology Sammons Cancer Center, Dallas
Local Institution - 0692, Galveston
Local Institution - 0652, Laredo
외 2개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06875310

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Next Oncology - Austin, Austin
Next Oncology - Houston, Houston
Next Oncology - Dallas, Irving
외 1개

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07488676

An External Control Arm Study in Non-Small Cell Lung Cancer

Oncology Consultants, Houston

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174388

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Oncology Consultants, P.A., Houston

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07028489

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.